跳至主要内容
临床试验/NCT01253824
NCT01253824已完成3 期

Pharmacodynamics of NPC-01( 1mg Norethisterone and 0.02mg Ethinyl Estradiol) and IKH-01( 1mg Norethisterone and 0.035mg Ethinyl Estradiol); Effect of NPC-01 and IKH-01 on Serum Concentrations of Estradiol, Progesterone, FSH and LH.

Nobelpharma0 个研究点目标入组 14 人开始时间: 2011年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
14
主要终点
Comparing Estradiol AUC of Menstrual Period During Study Drug Administration With Pre and Post Study Drug Administration (Baseline(BL)-Study Drug Administration(SDA), Follow up(FU)-Study Drug Administration(ADA))

研究概览

简要总结

The purpose of this study is to compare the serum levels of estradiol, progesterone, FSH and LH in NPC-01 or IKH-01 one treatment cycle with those in before and after administration cycle.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Healthy female aged between 20 to 35 years
  • BMI:18.0-26.0

排除标准

  • Females who are pregnant
  • Drug use affecting sex hormone secretion

研究组 & 干预措施

NPC-01

Experimental

1mg norethisterone and 0.02mg ethinyl estradiol

干预措施: NPC-01 (Drug)

IKH-01

Active Comparator

1mg norethisterone and 0.35mg ethinyl estradiol

干预措施: IKH-01 (Drug)

结局指标

主要结局

Comparing Estradiol AUC of Menstrual Period During Study Drug Administration With Pre and Post Study Drug Administration (Baseline(BL)-Study Drug Administration(SDA), Follow up(FU)-Study Drug Administration(ADA))

时间窗: Day 3, 6, 9, 12, 15, 18, 21, 24 of menstrual cycles

Estradiol was measured on day 3, 6, 9, 12, 15, 18, 21, 24 on 3 consecutive menstrual period (pre administration/Baseline(BL), study drug administration(SDA), post administration/follow up(FU)) and calculated AUC from these data

Comparing Progesterone AUC of Menstrual Period During Study Drug Administration With Pre and Post Study Drug Administration (Baseline(BL)-Study Drug Administration(SDA), Follow up(FU)-Study Drug Administration(ADA))

时间窗: Day 3, 6, 9, 12, 15, 18, 21, 24 of menstrual cycles

Progesterone was measured on day 3, 6, 9, 12, 15, 18, 21, 24 on 3 consecutive menstrual period (pre administration/Baseline(BL), study drug administration(SDA), post administration/follow up(FU)) and calculated AUC from these data

次要结局

  • Comparing FSH AUC of Menstrual Period During Study Drug Administration With Pre and Post Study Drug Administration (Baseline(BL)-Study Drug Administration(SDA), Follow up(FU)-Study Drug Administration(ADA))(Day 3, 6, 9, 12, 15, 18, 21, 24 of menstrual cycles)
  • Comparing LH AUC of Menstrual Period During Study Drug Administration With Pre and Post Study Drug Administration (Baseline(BL)-Study Drug Administration(SDA), Follow up(FU)-Study Drug Administration(ADA))(Day 3, 6, 9, 12, 15, 18, 21, 24 of menstrual cycles)

研究者

发起方
Nobelpharma
申办方类型
Industry
责任方
Sponsor

相似试验